Browse 24950 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 13th, 2023 |
Systems to End the Malaria Burden Through Meaningful Engagement - I (SEMBE I) |
Ghana USAID Accra |
February 14th, 2023 |
Assuring Radiation Protection (U18) Clinical Trial Not Allowed |
Food and Drug Administration |
July 27th, 2023 |
Opportunities for Advancing Limb Regeneration Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2026 |
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2026 |
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional) |
National Institutes of Health |
October 19th, 2023 |
Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed) |
National Institutes of Health |
December 2nd, 2022 |
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) |
National Institutes of Health |
February 3rd, 2023 |
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
November 17th, 2025 |
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
January 7th, 2026 |
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2023 |
Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed) |
National Institutes of Health |
December 20th, 2022 |
Mozambique Local Tuberculosis Response II |
Mozambique USAID Maputo |
December 20th, 2022 |
Mozambique Local Tuberculosis Response II |
Mozambique USAID Maputo |
December 2nd, 2025 |
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) |
National Institutes of Health |
December 2nd, 2025 |
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) |
National Institutes of Health |
October 23rd, 2025 |
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) |
National Institutes of Health |
October 23rd, 2025 |
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 17th, 2023 |
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) |
National Institutes of Health |
March 29th, 2023 |
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
May 4th, 2023 |
International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
|
January 27th, 2025 |
Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32) |
National Institutes of Health |
June 6th, 2023 |
Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States |
Centers for Disease Control NCHHSTP |
December 5th, 2025 |
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
December 5th, 2025 |
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 20th, 2023 |
Countering Stigma and Prejudice Against the Transgender Community |
US Mission to India |
April 18th, 2023 |
Regional Partnerships to Strengthen National Data Capacities for HIV, TB, and Other Pandemic Preparedness and Response under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
January 12th, 2023 |
Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 12th, 2023 |
Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2026 |
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
National Institutes of Health |
April 19th, 2024 |
Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) |
National Institutes of Health |
January 19th, 2023 |
Accelerate TB Elimination and Program Resilience Activity 2 |
South Africa USAID Pretoria |
February 28th, 2023 |
NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required) |
National Institutes of Health |
February 28th, 2023 |
NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required) |
National Institutes of Health |
February 28th, 2023 |
NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required) |
National Institutes of Health |
May 3rd, 2023 |
HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) |
Agency for International Development |
February 9th, 2023 |
Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China |
Centers for Disease Control and Prevention ERA |
February 10th, 2023 |
HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional) |
National Institutes of Health |
February 10th, 2023 |
HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional) |
National Institutes of Health |
March 23rd, 2023 |
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
April 7th, 2023 |
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) |
National Institutes of Health |